A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

A Novant Health doctor weighs in on the long term impacts of GLP-1 medications. Why You Should Always Ask for a Receipt at ...

There has been a 27% YoY increase in sales of weight-loss drugs, especially after the launch of Mounjaro and Novo Nordisk's ...

Emerging concerns link GLP-1 use, found in weight loss drugs like Wegovy/Ozempic and Mounjaro, to potential thyroid cancer ...

Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...

Obesity medicine specialist Sue Pedersen says the updates also focus on individualizing care and move away from relying on ...

Gibbs puts a patient's volume of food noise down to a mix of genetics, environment, socialisation and food availability. Too ...

Kilow, Saudi Arabia’s leading digital health and weight loss platform, is proud to announce the official launch of Kilow ...

Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...

Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending ...